CTOs on the Move

LifeScript

www.lifescript.com

 
LifeScript is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Blood Bank of Hawaii

The Blood Bank of Hawaii is a non-profit organization that provides lifesaving blood products to 11 civilian hospitals on Oahu and eight civilian hospitals on the neighbor islands. Typical uses for the blood include surgical procedures, treatment of

MINT dentistry

MINT dentistry is the fastest growing privately-owned and innovative dental practice in the United States. We hire only the most talented artists – true Cosmetic Dentists – and then train them to Mint`s exacting standards. MINT dentists have been named “Best Dentist in Dallas,” and “Best Dentist in Houston” by the International Academy of Elite Cosmetic Dentistry the last two years, named “Best Family Dentists” by Consumer`s Choice the last two years, recognized by Living Magazine as “Outstanding Dentists”, recognized by Modern Luxury Dallas and Modern Luxury Houston as “Elite Doctors” and have garnered numerous other accolades from countless other sources. MINT dentistry took the industry over with our expertise in General and Cosmetic dentistry. The year after MINT opened, Dr. Harrison, the founder and CEO, invented a procedure to lengthen teeth in conjunction with veneers (lengthening teeth is needed for patients with short teeth, gingiva overgrowth, or smiles with too much gum showing). After revolutionizing Cosmetic Dentistry, we then reexamined every technique in General Dentistry, which is very technique sensitive. We questioned everything, and tried every material and technique on the market because we wanted our patients to have the best. As Mint grew, we focused on reducing complication rates. Most dental offices strive to achieve a 10% complication rate. Mint has succeeded in achieving a 1/1000th complication rate by developing the Mint Standards of Dentistry. These Standards specify our materials and our new techniques that we train dentists to use (it`s our secret sauce). Mint offers you dentists who work as a team (we invented this as well), extraordinary prices, and an insurance department that handles everything. Plus incredible payment plans and industry changing techniques. All this to be said you have to experience MINT dentistry to appreciate it, because it`s like nothing you`ve ever experienced.

Viome

Viome is the first company to offer wellness as a service. We apply artificial intelligence to complex biological data to provide personalized recommendations for healthy living.

Hanna Boys Ctr

Hanna Boys Ctr is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Sonoma, CA. To find more information about Hanna Boys Ctr, please visit www.hannacenter.org

Discovery Laboratories Inc

Discovery Laboratories, Inc. is a specialty biotechnology company focused on advancing a new standard in respiratory critical care. Discovery Labs` technology platform includes its novel proprietary KL4 surfactant, a synthetic, peptide-containing surfactant that is structurally similar to pulmonary surfactant, and its proprietary drug delivery technologies being developed to enable efficient delivery of aerosolized KL4 surfactant and other inhaled therapies. Discovery Labs` strategy is initially focused on neonatology and improving the management of respiratory distress syndrome (RDS) in premature infants. Discovery Labs believes that its RDS product portfolio has the potential to become the new standard of care for RDS and, over time, enable the treatment of a significantly greater number of premature infants who could benefit from surfactant therapy that are currently not being treated. In many pulmonary diseases, including RDS, acute lung injury (ALI), and other respiratory conditions, surfactant is either deficient or may fail to function properly. Our precision-engineered, peptide-containing KL4 surfactant has been designed to mimic the essential function of human pulmonary surfactant and may have the potential to address conditions such as these. We are developing our proprietary delivery technologies to one day enable efficient, targeted upper-respiratory or alveolar delivery of our KL4 surfactant in aerosolized form to allow for a gentler, less invasive delivery approach. These same delivery systems may also potentially be used to deliver a variety of additional aerosolized medicines safely and in a simplified way compared with the current standard of care.